Some reports and a meta-analysis suggest that several non-live inactivated vaccines (hepatitis A, hepatitis B, influenza, and Streptococcus pneumoniae) may not elicit adequate seroprotection when administered to adult IBD patients treated with anti-TNF agents [83,306,307,308,309]. This evidence concerns the gene TNF and hepatitis B virus infection.